GoodRx Holdings, Inc., is an American healthcare company that operates a telemedicine platform and free-to-use website and mobile app that track prescription drug prices in the United States and provide drug coupons for discounts on medications. GoodRx checks drug prices at more than seventy-five thousand pharmacies in the United States. The platform allows individuals to consult with a doctor online and obtain a prescription for certain types of medications at a cost of US$20, regardless of insurance status. Medical testing services, which vary in price, are also offered through the platform.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| GDRX | GoodRx Holdings, Inc. | 2025-10-30 18:58:04 | 3.5 | 0.06 | 1.74 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GDRX | 0001809519 | GoodRx Holdings, Inc. | US38246G1085 | — | 475104396 | Nasdaq | 7374 | Services-Computer Processing & Data Preparation | 1231 | DE | 2701 OLYMPIC BOULEVARD | SANTA MONICA | CA | 90404 | UNITED STATES | US | (855) 268-2822 | 2701 OLYMPIC BOULEVARD, SANTA MONICA, CA, 90404 | 2701 OLYMPIC BOULEVARD, SANTA MONICA, CA, 90404 | — | — | 2011 | Trevor Bezdek | 777 | http://goodrx.com | 646,300,000 | — | — | GoodRx Holdings, Inc., is an American healthcare company that operates a telemedicine platform and free-to-use website and mobile app that track prescription drug prices in the United States and provide drug coupons for discounts on medications. GoodRx checks drug prices at more than seventy-five thousand pharmacies in the United States. The platform allows individuals to consult with a doctor online and obtain a prescription for certain types of medications at a cost of US$20, regardless of insurance status. Medical testing services, which vary in price, are also offered through the platform. | 2025-10-30 14:17:14 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 646,300,000 | 222,400,000 | 52.4652 | — | — | — |
| 2023 | 423,900,000 | -48,200,000 | -10.2097 | — | — | — |
| 2022 | 472,100,000 | -1,827,900,000 | -79.4739 | — | — | — |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Trevor Bezdek | Chairman Of The Board | 2024 | 500,000 | 398 | 0 | 302,300 | 51,220 | 853,918 |
| Romin Nabiey | Chief Accounting Officer | 2024 | 326,627 | 286 | 257,870 | 98,520 | 9,303 | 942,603 |
| Scott Wagner | Chief Executive Officer | 2024 | 750,000 | 750,212 | 3,902,298 | 363,969 | 997 | 9,767,472 |
| Karsten Voermann | Chief Financial Officer | 2024 | 450,000 | 443 | 2,578,753 | 272,070 | 35,338 | 5,836,601 |
| Raj Beri | Chief Operating Officer | 2024 | 62,500 | 0 | 0 | 0 | 1,916,555 | 2,878,472 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 738 |
| 2023 | 694 |
| 2022 | 954 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 792,324,000 | 750,265,000 | 766,554,000 |
| Cost Of Revenue | 48,215,000 | 66,925,000 | 65,079,000 |
| Gross Profit | — | — | — |
| Research And Development Expenses | 123,749,000 | 135,836,000 | 143,137,000 |
| General And Administrative Expenses | 117,862,000 | 125,515,000 | 144,792,000 |
| Operating Expenses | 726,478,000 | 777,272,000 | 764,816,000 |
| Operating Income | 65,846,000 | -27,007,000 | 1,738,000 |
| Net Income | 16,390,000 | -8,868,000 | -32,828,000 |
| Earnings Per Share Basic | 0.04 | -0.02 | -0.08 |
| Earnings Per Share Diluted | 0.04 | -0.02 | -0.08 |
| Weighted Average Shares Outstanding Basic | 385,737,000 | 410,315,000 | 412,858,000 |
| Weighted Average Shares Outstanding Diluted | 392,172,000 | 410,315,000 | 412,858,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 448,346,000 | 672,296,000 | 757,165,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 145,934,000 | 143,608,000 | 117,141,000 |
| Inventories | — | — | — |
| Non Trade Receivables | 0 | 3,537,000 | 4,524,000 |
| Other Assets Current | — | — | 35,105,000 |
| Total Assets Current | 659,255,000 | 872,790,000 | 919,686,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 12,664,000 | 15,932,000 | 19,820,000 |
| Other Assets Non Current | 23,520,000 | 37,775,000 | 27,165,000 |
| Total Assets Non Current | 728,812,000 | 716,010,000 | 684,945,000 |
| Total Assets | 1,388,067,000 | 1,588,800,000 | 1,604,631,000 |
| Accounts Payable | 14,137,000 | 36,266,000 | 17,700,000 |
| Deferred Revenue | 6,036,000 | 7,105,000 | 7,879,000 |
| Short Term Debt | 5,000,000 | 8,787,000 | 7,029,000 |
| Other Liabilities Current | 1,457,000 | — | — |
| Total Liabilities Current | 123,903,000 | 122,559,000 | 76,320,000 |
| Long Term Debt | 500,000,000 | 647,703,000 | 667,068,000 |
| Other Liabilities Non Current | 6,755,000 | 8,177,000 | 7,557,000 |
| Total Liabilities Non Current | 539,506,000 | 704,283,000 | 713,484,000 |
| Total Liabilities | 663,409,000 | 826,842,000 | 789,804,000 |
| Common Stock | 38,000 | 40,000 | 40,000 |
| Retained Earnings | -1,441,013,000 | -1,457,403,000 | -1,448,535,000 |
| Accumulated Other Comprehensive Income | — | — | — |
| Total Shareholders Equity | 724,658,000 | 761,958,000 | 814,827,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 69,538,000 | 107,668,000 | 54,177,000 |
| Share Based Compensation Expense | 99,026,000 | 104,820,000 | 120,234,000 |
| Other Non Cash Income Expense | 0 | -1,348,000 | — |
| Change In Accounts Receivable | 2,326,000 | 26,467,000 | -1,375,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | -164,000 | 164,000 | -80,000 |
| Change In Accounts Payable | -21,241,000 | 17,456,000 | -874,000 |
| Change In Other Liabilities | -1,422,000 | 914,000 | 2,125,000 |
| Cash From Operating Activities | 183,892,000 | 138,292,000 | 146,780,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 1,240,000 | 1,043,000 | 3,967,000 |
| Acquisition Of Business | 0 | 0 | 156,853,000 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -70,347,000 | -55,766,000 | -210,498,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 1,766,000 | 1,390,000 | — |
| Repurchase Of Common Stock | 159,704,000 | 103,974,000 | 101,721,000 |
| Issuance Of Long Term Debt | 472,033,000 | — | 0 |
| Repayment Of Long Term Debt | 639,038,000 | 5,271,000 | 7,029,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -337,495,000 | -167,395,000 | -120,226,000 |
| Change In Cash | -223,950,000 | -84,869,000 | -183,944,000 |
| Cash At End Of Period | 448,346,000 | 672,296,000 | 757,165,000 |
| Income Taxes Paid | 23,623,000 | 17,243,000 | 4,356,000 |
| Interest Paid | 55,099,000 | 48,799,000 | 30,702,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 0.04 | -0.02 | -0.08 |
| Price To Earnings Ratio | 116.25 | -335 | -58.25 |
| Earnings Growth Rate | -300 | -75 | 33.3333 |
| Price Earnings To Growth Ratio | -0.3875 | 4.4667 | -1.7475 |
| Book Value Per Share | 1.8786 | 1.857 | 1.9736 |
| Price To Book Ratio | 2.4752 | 3.608 | 2.3611 |
| Ebitda | 162,473,000 | 172,771,000 | 59,948,000 |
| Enterprise Value | 1,850,331,050 | 2,733,304,500 | 1,840,850,280 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.6969 | 0.8616 | 0.8273 |
| Capital Expenditures | 66,270,000 | 103,780,000 | 52,385,000 |
| Free Cash Flow | 117,622,000 | 34,512,000 | 94,395,000 |
| Return On Equity | 0.0226 | -0.0116 | -0.0403 |
| One Year Beta | 0.8214 | 1.9785 | 2.1936 |
| Three Year Beta | 1.9316 | 2.0121 | 1.9432 |
| Five Year Beta | 1.805 | 1.9504 | 1.9432 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Hirsch Douglas Joseph | Director | 2025-10-26 | 20,521 | A | 231,909 |
| Hirsch Douglas Joseph | Director | 2025-10-26 | 20,521 | D | 41,042 |
| Spectrum Equity VII, L.P. | 10% owner | 2025-10-15 | 15,202 | D | 0 |
| Spectrum Equity VII, L.P. | 10% owner | 2025-10-14 | 8,881,362 | A | 8,881,362 |
| Spectrum Equity VII, L.P. | 10% owner | 2025-10-14 | 15,202 | A | 15,202 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Anthony E. Gonzalez | 2021-04-23 | OH16 | Purchase | 2021-03-25 | — | $100,001 - $250,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| TEACHER RETIREMENT SYSTEM OF TEXAS | 2025-09-30 | 584,290 | 138,130 | 4.23 |
| Covestor Ltd | 2025-09-30 | 7,000 | 1,591 | 4.3997 |
| Root Financial Partners, LLC | 2025-09-30 | 51 | 12 | 4.25 |
| WPG Advisers, LLC | 2025-09-30 | 288 | 68 | 4.2353 |
| Campbell & CO Investment Adviser LLC | 2025-09-30 | 189,081 | 44,700 | 4.23 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Exchange Place Advisors Trust | 2025-08-31 | Class I | NKMCX | 6,447 | 28,044.45 | 0.0975 |
| RBB FUND, INC. | 2025-08-31 | Motley Fool Next Index ETF | TMFX | 5,981 | 26,017.35 | 0.0784 |
| AMERICAN CENTURY ETF TRUST | 2025-08-31 | Avantis U.S. Small Cap Equity ETF | AVSC | 70,455 | 306,479.25 | 0.0163 |
| AMERICAN CENTURY ETF TRUST | 2025-08-31 | Institutional Class | AVSBX | 937 | 4,075.95 | 0.0038 |
| AMERICAN CENTURY ETF TRUST | 2025-08-31 | G Class | AVSCX | 937 | 4,075.95 | 0.0038 |